These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16140543)

  • 1. Colorectal cancer after orthotopic liver transplantation.
    Silva MA; Jambulingam PS; Mirza DF
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in post-liver transplant recipients.
    Sint Nicolaas J; Tjon AS; Metselaar HJ; Kuipers EJ; de Man RA; van Leerdam ME
    Dis Colon Rectum; 2010 May; 53(5):817-21. PubMed ID: 20389217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for cancer after liver transplantation.
    Vallejo GH; Romero CJ; de Vicente JC
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):87-99. PubMed ID: 15979889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with the development of skin cancer after liver transplantation.
    Mithoefer AB; Supran S; Freeman RB
    Liver Transpl; 2002 Oct; 8(10):939-44. PubMed ID: 12360438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
    Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT
    Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Andrés A
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention and screening in primary sclerosing cholangitis.
    Kitiyakara T; Chapman RW
    Postgrad Med J; 2008 May; 84(991):228-37. PubMed ID: 18508979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo malignancies following liver transplantation: impact and recommendations.
    Herrero JI
    Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L; Sokol H; Seksik P
    Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.